# Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients

> **NCT02225886** · PHASE4 · UNKNOWN · sponsor: **Anemia Working Group Romania** · enrollment: 100 (estimated)

## Conditions studied

- Anaemia Response to the Treatment
- Peripheral Iron Indices
- Oxalemia

## Interventions

- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT02225886
- **Lead sponsor:** Anemia Working Group Romania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2023-03
- **Final completion:** 2023-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02225886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02225886, "Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02225886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*